Modified gamma camera zeroes in on subcentimeter breast lesions
Researchers at the Mayo Clinic in Rochester, MN, have developed a molecular breast imaging technique that uses a cadmium-zinc-telluride semiconductor detector.
Researchers at the Mayo Clinic in Rochester, MN, have developed a molecular breast imaging technique that uses a cadmium-zinc-telluride semiconductor detector.
The investigators mounted a gamma camera, which has a field-of-view of 20 x 20 cm and detector elements of 2.5 x 2.5 mm, onto a modified mammographic gantry. Between November 2001 and March 2004, they imaged 40 women who were scheduled for biopsy. The study was published in the January issue of the Mayo Clinic Proceedings.
Using 20 mCi of technetium-99m sestamibi, they obtained craniocaudal and mediolateral oblique views of both breasts. The imaging technique detected 33 of 36 lesions confirmed to be malignant by surgery, for an overall sensitivity of 92%. It detected 19 of 22 surgery-confirmed lesions smaller than 1 cm, for a sensitivity of 86%.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
